Cardiovascular surgeon. Consultant surgeon Hospital Universitario de Caracas. Head cardiovascular surgery Centro medico docente la Trinidad. [email protected]
For subset of pts w/ Ascending aortic aneurysm (not root) that requires operation, & #BicuspidAorticValve that functions well, just fixing the aneurysm and leaving the #BAV is ok. Freedom from valve op is 95% @ 5y 83% @ 10y 63% @ 15y & reops safe #AortaEd https://t.co/r4CuHFcH4W
A large cohort @CleClinicHVTI study shows that valve reimplantation in these patients can provide excellent event-free survival & aortic valve function without the need for anticoagulation conferred by mechanical valves.
@SKalahastiMD@MarfanFdn#AortaEd
https://t.co/2XcZScyIeS
Great debate just published in #EHJ: all patients with asymptomatic severe aortic stenosis need valve replacement.
https://t.co/2BclgoYvKj
#aorticstenosis@escardio@ESC_Journals
incorporated aortomitral homograft for double-valve endocarditis: the ‘hemi-Commando’ procedure. Early and mid-term outcomes† https://t.co/EWxbdAFWbX. #CCEndocarditis
Tense discussions about the 2023 @American_Heart@ACCinTouch chronic coronary guideline at the ACC board of trustees meeting this weekend in Vancouver. Expecting a joint statement soon addressing the controversy and ensuring fallout
Finally the official program for the First LACES meeting in Iguazu Falls. Take a peek and remember to submit abstracts !! Deadline 15th May. All accepted abstracts will be published.
Very solid data published today by the Low Risk Evolut trial from @Medtronic. This is a trial for which I take off my hat in respect. Nonetheless, this are my considerations…@drjohnm
Very solid data published today by the Low Risk Evolut trial from @Medtronic. This is a trial for which I take off my hat in respect. Nonetheless, this are my considerations…@drjohnm
M Gaudino et al 👉 “In the published PCI versus CABG trials, the reduction in all-cause mortality in the surgical arm is associated with the protective effect of CABG against SMI” https://t.co/bF02dAeq66